First Time Loading...

Genmab A/S
NASDAQ:GMAB

Watchlist Manager
Genmab A/S Logo
Genmab A/S
NASDAQ:GMAB
Watchlist
Price: 26.96 USD 2.74%
Updated: Jul 12, 2024
Have any thoughts about
Genmab A/S?
Write Note

Relative Value

The Relative Value of one GMAB stock under the Base Case scenario is 44.59 USD. Compared to the current market price of 26.96 USD, Genmab A/S is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GMAB Relative Value
Base Case
44.59 USD
Undervaluation 40%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
56
Median 3Y
13.3
Median 5Y
15.1
Industry
7.5
Forward
5.9
vs History
96
vs Industry
7
Median 3Y
35.5
Median 5Y
36.5
Industry
23.9
Forward
22.1
vs History
88
vs Industry
9
Median 3Y
31.8
Median 5Y
42.8
Industry
21.7
vs History
87
vs Industry
7
Median 3Y
33.4
Median 5Y
47
Industry
22.3
vs History
96
vs Industry
26
Median 3Y
6.3
Median 5Y
7.1
Industry
2.4
vs History
96
vs Industry
53
Median 3Y
11.5
Median 5Y
13.2
Industry
7.4
Forward
4.5
vs History
20
vs Industry
47
Median 3Y
0
Median 5Y
0
Industry
8.6
vs History
96
vs Industry
7
Median 3Y
25.2
Median 5Y
25.6
Industry
3.9
Forward
14.1
vs History
96
vs Industry
7
Median 3Y
25.2
Median 5Y
27
Industry
3.8
Forward
16.7
vs History
92
vs Industry
10
Median 3Y
28.8
Median 5Y
36.6
Industry
4.9
vs History
92
vs Industry
8
Median 3Y
29.9
Median 5Y
39.5
Industry
3.1
vs History
96
vs Industry
18
Median 3Y
23.7
Median 5Y
25.1
Industry
4.4

Multiples Across Competitors

GMAB Competitors Multiples
Genmab A/S Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Genmab A/S
NASDAQ:GMAB
120B USD 6.8 22 16.1 16.1
US
Abbvie Inc
NYSE:ABBV
301.4B USD 5.5 50.7 14.1 21.7
US
Amgen Inc
NASDAQ:AMGN
176.5B USD 6 46.8 19.5 32.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.7B USD 12.5 31.7 26.9 28.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
120.7B USD 9.2 31.3 25.4 28.2
AU
CSL Ltd
ASX:CSL
148.1B AUD 7.1 40.5 24.2 30
US
Gilead Sciences Inc
NASDAQ:GILD
87.5B USD 3.2 180.9 9.1 11.9
US
Moderna Inc
NASDAQ:MRNA
48.1B USD 9.3 -8.1 -8.8 -7.8
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33.6B USD 3.5 28.9 14.7 18.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
33.3B USD 16.6 -100.1 -261.5 -181.9
P/E Multiple
Earnings Growth
DK
Genmab A/S
NASDAQ:GMAB
Average P/E: 54.1
22
98%
US
Abbvie Inc
NYSE:ABBV
50.7
406%
US
Amgen Inc
NASDAQ:AMGN
46.8
75%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.7
50%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
31.3
50%
AU
CSL Ltd
ASX:CSL
40.5
81%
US
Gilead Sciences Inc
NASDAQ:GILD
180.9
70%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -8.1 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -57.5 N/A
US
Biogen Inc
NASDAQ:BIIB
28.9
148%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -100.1 N/A
EV/EBITDA Multiple
EBITDA Growth
DK
Genmab A/S
NASDAQ:GMAB
Average EV/EBITDA: 18.7
16.1
96%
US
Abbvie Inc
NYSE:ABBV
14.1
28%
US
Amgen Inc
NASDAQ:AMGN
19.5
58%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
60%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
25.4
52%
AU
CSL Ltd
ASX:CSL
24.2
53%
US
Gilead Sciences Inc
NASDAQ:GILD
9.1
16%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -8.8 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -61.9 N/A
US
Biogen Inc
NASDAQ:BIIB
14.7
56%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -261.5 N/A
EV/EBIT Multiple
EBIT Growth
DK
Genmab A/S
NASDAQ:GMAB
Average EV/EBIT: 23.3
16.1
89%
US
Abbvie Inc
NYSE:ABBV
21.7
88%
US
Amgen Inc
NASDAQ:AMGN
32.2
95%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.1
58%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.2
52%
AU
CSL Ltd
ASX:CSL
30
68%
US
Gilead Sciences Inc
NASDAQ:GILD
11.9
33%
US
Moderna Inc
NASDAQ:MRNA
Negative Multiple: -7.8 N/A
US
Seagen Inc
NASDAQ:SGEN
Negative Multiple: -55.8 N/A
US
Biogen Inc
NASDAQ:BIIB
18.3
71%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -181.9 N/A

See Also

Discover More